Intrahepatic cholangiocarcinoma and combined hepatocellular- cholangiocarcinoma: A Western experience

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1880-1890

  Portolani, Nazario ^a   Baiocchi, Gian Luca ^a   Coniglio, Arianna ^a   Piardi, Tullio ^a   Grazioli, Luigi ^b   Benetti, Anna ^a   Ferrari Bravo, Andrea ^a   Giulini, Stefano Maria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Cholangiocarcinoma; Cirrhosis; HCC; Hepatitis infection; Liver surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHRONIC LIVER DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; TREATMENT CONTRAINDICATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 46149127546     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9933-y     Document Type: Article

References (38)

1. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89:1525-31
2. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology. J Gastroenterol Hepatol 2002; 17:1049-55
3. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193:134-41
4. Huang JL, Biehl TR, Lee FT, et al. Outcomes after resection of cholangiocellular carcinoma. Am J Surg 2004; 87:612-7
5. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004; 40:298-304
6. Nakamura S, Suzuki S, Sakaguchi T, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer 1996; 78:1671-6
7. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998; 13:34-40
8. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11:758-64
9. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94:2040-6
10. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, et al. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004; 41:292-8
11. Green FL (ed.) AJCC cancer staging manual, 6th edn. New York: Springer Verlag, 2002
12. Liver cancer study group of Japan. Classification of primary liver cancer, 1st edn. Tokyo: Kanahara, 1997
13. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55:124-35
14. Kojiro M. Patomorphology of advanced hepatocellular carcinoma. In: Tobe K, Kameda H, Okudaira M, et al. (eds) Primary liver cancer in Japan. Tokyo: Springer-Verlag 1992, pp 31-37
15. Nagafuchi Y, Okamoto K, Shono M, et al. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients. Hepatogastroenterology 1998; 45:523-7
16. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003; 138:86-90
17. Koh KC, Lee H, Choi MS, et al. Clinicopathological features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189:120-5
18. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33:283-7
19. Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma (HCC). Prognostic and therapeutic implications. Ann Surg 2006; 243:229-35
20. Chiesa R, Donato F, Portolani N, et al. Primary liver cancer in a high incidence area in north Italy: ethiological hypotheses arising from routinely collected data. Eur J Epidem 1995; 6:435-42
21. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma : the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155:323-31
22. Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88:2471-7
23. Han SL, Zhu GB, Yao JG, et al. Diagnosis and surgical treatment of primary hepatic cholangiocarcinoma. Hepatogastroenterology 2005; 52:348-51
24. Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: analysis of single-center experience and review of the literature. Liver Transplantation 2001; 7:1023-33
25. Valverde A, Bonhomme N, Farges O, et al. Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 1999; 6:122-7
26. Kaczynski J, Hansson G, Wallersted S. Incidence, etiologic aspects and clinicophatologic features in intrahepatic cholangiocellular carcinoma: a study of 51 cases from a low-endemicity area. Acta Oncol 1998; 37:77-83
27. Roayaie S, Guarrera J, Ye MQ, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998; 187:365-72
28. Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 1998; 85:1206-9
29. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463-75
30. Nozaki Y, Yamamoto M, Ikai I, et al. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the international union against cancer TNM staging system for primary liver carcinoma. Cancer 2001; 83:1923-9
31. Isa T, Kusano T, Shimoji H, et al. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001; 181:507-11
32. Inoue M, Makuuchi T, Takayama, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127:498-505
33. Grobmyer SR, Wang L, Gonen M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006; 244:260-4
34. Akatsu T, Shimazu M, Kawachi S, et al. Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. Hepatogastroenterology 2005; 52:603-5
35. Lang H, Sotiropulos GC, Fruhauf NR, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC). Ann Surg 2005; 241:134-43
36. Puhalla H, Schuell B, Pokorny H, et al. Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg 2005; 189:173-7
37. Slakey DP. Radiofequency ablation of recurrent cholangiocarcinoma. Am Surg 2002; 68:395-7
38. Shirabe K, Shimada M, Tsujita E. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 2004; 187:538-42